Thai State Council Takes Up Compulsory Licensing Issue
This article was originally published in PharmAsia News
Executive Summary
Thailand's Council of State has taken up the issue of the whether the Public Health Ministry's policy of imposing compulsory licensing on foreign drug makers is legal. Sanofi Aventis of France, seeking to protect the patent on its Taxotere (doxetaxel) breast cancer drug, earlier petitioned the government to review the ministry's CL policy, which the company said violates two articles of the nation's Patent Act. The Commerce Ministry, given authority over such issues by the act, sought a ruling by the Council of State. The AIDS Access Foundation has urged the council to keep the CL policy in place. (Click here for more